Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
B. Keymeulen, M. Walter, C. Mathieu, L. Kaufman, F. Gorus, R. Hilbrands, E. Vandemeulebroucke, U. Van De Velde, L. Crenier, C. De Block, S. Candon, H. Waldmann, A. G. Ziegler, L. Chatenoud, D. Pipeleers
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
288Zitate
(Scopus)
Fingerprint
Untersuchen Sie die Forschungsthemen von „Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass“. Zusammen bilden sie einen einzigartigen Fingerprint.